We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$237M
AUM Growth
+$17.9M
Cap. Flow
+$325K
Cap. Flow %
0.14%
Top 10 Hldgs %
29.98%
Holding
77
New
4
Increased
27
Reduced
36
Closed
4

Top Buys

Rank Stock Value
1
NEU icon
NewMarket
NEU
+$588K
2
AMGN icon
Amgen
AMGN
+$557K
3
TJX icon
TJX Companies
TJX
+$494K
4
CNI icon
Canadian National Railway
CNI
+$386K
5
CLB icon
Core Laboratories
CLB
+$356K

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$790K
2
PII icon
Polaris
PII
+$626K
3
GILD icon
Gilead Sciences
GILD
+$563K
4
PG icon
Procter & Gamble
PG
+$457K
5
CLX icon
Clorox
CLX
+$299K

Sector Composition

Rank Sector Weight
1 Technology 18.18%
2 Consumer Discretionary 17.52%
3 Healthcare 17.36%
4 Industrials 13.36%
5 Consumer Staples 10.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
76
Procter & Gamble
PG
$346B
– –
-5,940
Closed -$457K
1 2 3
4

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return

JLB & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, JLB & Associates held 77 positions worth $237M, up 8.2% from $219M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

JLB & Associates's Q3 2013 filing shows 4 new, 27 increased, 36 reduced and 4 closed positions. Its largest new stake was Core Laboratories: 2,295 shares worth $388K. The largest sale was Lockheed Martin, an estimated $790K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • JLB & Associates's largest Q3 2013 buy was Core Laboratories: 2,295 shares worth $388K.
  • JLB & Associates added most to NewMarket in Q3 2013, an estimated $588K increase.
  • JLB & Associates's biggest Q3 2013 reduction was Polaris, cutting an estimated $626K.
  • JLB & Associates fully exited Lockheed Martin in Q3 2013, selling an estimated $790K.
  • JLB & Associates's ten largest holdings make up 30% of its $237M portfolio in Q3 2013.
  • JLB & Associates opened 4 new positions and closed 4 in Q3 2013.
  • JLB & Associates's portfolio value rose 8.2% quarter-over-quarter to $237M.

Based on JLB & Associates's 13F filing for Q3 2013, filed 7 Oct 2013.